一个发展中国家实现高值救命药全民可及的成功经验及对我国的启示

发布时间：2019-02-09 17:24

【摘要】：目的:为我国促进高值救命药全民可及提出政策建议。方法:通过查阅文献和对知情人士访谈回顾分析泰国的医疗保障体系、基本药物制度、医疗服务和药品采购供应体系、抗艾滋病药可及性策略、药品准入机制、高值救命药全民可及促进策略及对我国的启示。结果与结论:泰国响应国际社会将治疗重大疾病、疗效确定、且临床无可替代的高值专利药纳入基本药物的理念,制定了国家基本药物目录高值药特殊目录和定期更新机制,建立了可持续的筹资和保障供应体系,以卫生技术评估服务于药物政策,充分利用国际公约赋予发展中国家的合法权益,以国内配套法律为依据,通过国家谈判和政府各部门间及与非政府部门的携手努力,获得了可负担的价格。上述经验对我国实现高值救命药全民可及提供了一定借鉴。
[Abstract]:Objective: to put forward some policy suggestions for promoting the availability of high-value lifesaving drugs in China. Methods: Thailand's medical security system, essential drug system, medical service and drug procurement and supply system, anti-AIDS drug accessibility strategy, and drug access mechanism were analyzed retrospectively through literature review and interviews with informed persons. High-value lifesaving drugs are available to the whole people and their enlightenment to our country. Results & conclusion: in response to the international community's idea of integrating high-value patent drugs for the treatment of major diseases, the efficacy of which is determined, and the clinically irreplaceable high-value patent drugs, Thailand has developed a special list of high-value drugs and a mechanism for regular updating of the national catalogue of essential drugs. Establishing sustainable financing and security of supply systems, serving drug policy with health technology assessments, making full use of the legitimate rights and interests conferred on developing countries by international conventions and based on supporting domestic laws, Affordable prices have been obtained through national negotiations and joint efforts between government departments and the non-government sector. The above experience has provided some reference for the realization of high-value lifesaving drugs in our country.
【作者单位】：中国医学科学院北京协和医学院公共卫生学院;
【基金】：国家卫生计生委药政司委托研究课题(No.药政[2016]9号)
【分类号】：R95

【相似文献】